|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
|
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Cash and cash equivalents | ||||||
| Cash | ||||||
| Prepaid expenses | ||||||
| Total Current Assets | ||||||
| Long-term prepaid insurance | ||||||
| Deferred offering costs | ||||||
| Cash and marketable securities held in Trust Account | ||||||
| Total Assets | ||||||
| Liabilities, Class A Shares Subject to Possible Redemption, and Shareholders’ Deficit: | ||||||
| Accrued expenses | ||||||
| Promissory note - related party | ||||||
| Accrued offering costs | ||||||
| Total Current Liabilities | ||||||
| Advisory fee payable | ||||||
| Deferred underwriting fee | ||||||
| Total Liabilities | ||||||
| Class A Ordinary Shares subject to possible redemption, 22,000,000 shares at redemption value of $10.56 and $10.37 per share as of June 30, 2026 and December 31, 2025, respectively | ||||||
| Common Class A | ||||||
| Total class A Ordinary Shares subject to possible redemption, 22,000,000 shares at redemption value of $10.56 and $10.37 per share as of June 30, 2026 and December 31, 2025, respectively | ||||||
| Shareholders’ Deficit | ||||||
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of June 30, 2026 and December 31, 2025 | ||||||
| Ordinary shares | ||||||
| Common Class A | ||||||
| Class B Ordinary Shares | ||||||
| Additional paid-in capital | ||||||
| Accumulated deficit | ||||||
| Total Shareholders’ Deficit | ||||||
| Total Liabilities, Class A Shares Subject to Possible Redemption, and Shareholders’ Deficit |
Loading...
